Market Closed -
Nyse
01:30:02 01/06/2024 am IST
|
5-day change
|
1st Jan Change
|
19.81
USD
|
+0.41%
|
|
+4.32%
|
+39.90%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,620
|
2,099
|
3,697
|
2,118
|
2,220
|
3,127
|
-
|
-
|
Enterprise Value (EV)
1 |
4,344
|
4,801
|
6,045
|
4,492
|
4,771
|
5,595
|
5,384
|
5,196
|
P/E ratio
|
-14.6
x
|
-
|
13.3
x
|
4.34
x
|
-
|
-
|
15.2
x
|
13.2
x
|
Yield
|
1.58%
|
1.92%
|
1.5%
|
3.65%
|
-
|
1.26%
|
1.26%
|
1.26%
|
Capitalization / Revenue
|
0.61
x
|
0.76
x
|
1.04
x
|
0.61
x
|
0.78
x
|
0.97
x
|
0.91
x
|
0.88
x
|
EV / Revenue
|
1.64
x
|
1.74
x
|
1.69
x
|
1.3
x
|
1.67
x
|
1.74
x
|
1.56
x
|
1.46
x
|
EV / EBITDA
|
7.06
x
|
7.19
x
|
6.38
x
|
5.13
x
|
9.11
x
|
8.8
x
|
6.96
x
|
6.28
x
|
EV / FCF
|
20.3
x
|
30
x
|
12.9
x
|
26.4
x
|
-62
x
|
35.9
x
|
20.2
x
|
16.9
x
|
FCF Yield
|
4.93%
|
3.33%
|
7.74%
|
3.78%
|
-1.61%
|
2.79%
|
4.94%
|
5.91%
|
Price to Book
|
2.17
x
|
1.24
x
|
1.86
x
|
0.9
x
|
1.15
x
|
1.57
x
|
1.45
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
1,41,889
|
1,43,557
|
1,53,867
|
1,54,465
|
1,56,794
|
1,57,839
|
-
|
-
|
Reference price
2 |
11.42
|
14.62
|
24.03
|
13.71
|
14.16
|
19.81
|
19.81
|
19.81
|
Announcement Date
|
25/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,642
|
2,758
|
3,572
|
3,454
|
2,850
|
3,220
|
3,441
|
3,555
|
EBITDA
1 |
615
|
668
|
947
|
875
|
524
|
636
|
773.3
|
827.1
|
EBIT
1 |
303
|
334
|
619
|
580
|
249
|
338.3
|
469.1
|
528.8
|
Operating Margin
|
11.47%
|
12.11%
|
17.33%
|
16.79%
|
8.74%
|
10.5%
|
13.63%
|
14.88%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
308
|
49
|
174.8
|
313.4
|
353.5
|
Net income
1 |
-109
|
969
|
286
|
497
|
-316
|
99.25
|
225.8
|
255.3
|
Net margin
|
-4.13%
|
35.13%
|
8.01%
|
14.39%
|
-11.09%
|
3.08%
|
6.56%
|
7.18%
|
EPS
|
-0.7800
|
-
|
1.810
|
3.160
|
-
|
-
|
1.300
|
1.500
|
Free Cash Flow
1 |
214
|
160
|
468
|
170
|
-77
|
156
|
266
|
307
|
FCF margin
|
8.1%
|
5.8%
|
13.1%
|
4.92%
|
-2.7%
|
4.84%
|
7.73%
|
8.64%
|
FCF Conversion (EBITDA)
|
34.8%
|
23.95%
|
49.42%
|
19.43%
|
-
|
24.53%
|
34.4%
|
37.12%
|
FCF Conversion (Net income)
|
-
|
16.51%
|
163.64%
|
34.21%
|
-
|
157.17%
|
117.8%
|
120.24%
|
Dividend per Share
2 |
0.1800
|
0.2800
|
0.3600
|
0.5000
|
-
|
0.2500
|
0.2500
|
0.2500
|
Announcement Date
|
25/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
884
|
965
|
945
|
895
|
649
|
708
|
794
|
662
|
686
|
774
|
860
|
812.6
|
799.2
|
850.6
|
926.9
|
EBITDA
1 |
233
|
240
|
275
|
247
|
113
|
146
|
168
|
116
|
94
|
131
|
169.9
|
180
|
165.9
|
187.5
|
225.9
|
EBIT
1 |
155
|
154
|
190
|
163
|
40
|
62
|
84
|
32
|
25
|
59
|
97.96
|
105.3
|
96.02
|
108.6
|
147.1
|
Operating Margin
|
17.53%
|
15.96%
|
20.11%
|
18.21%
|
6.16%
|
8.76%
|
10.58%
|
4.83%
|
3.64%
|
7.62%
|
11.39%
|
12.96%
|
12.02%
|
12.77%
|
15.86%
|
Earnings before Tax (EBT)
1 |
104
|
34
|
152
|
141
|
-19
|
34
|
53
|
-6
|
-32
|
2
|
47
|
45
|
48
|
-
|
-
|
Net income
1 |
83
|
16
|
375
|
121
|
-15
|
23
|
-269
|
-14
|
-56
|
-9
|
36
|
35
|
38
|
-
|
-
|
Net margin
|
9.39%
|
1.66%
|
39.68%
|
13.52%
|
-2.31%
|
3.25%
|
-33.88%
|
-2.11%
|
-8.16%
|
-1.16%
|
4.19%
|
4.31%
|
4.75%
|
-
|
-
|
EPS
2 |
0.5200
|
0.1000
|
2.370
|
0.7700
|
-0.0900
|
0.1500
|
-1.720
|
-0.0900
|
-0.3600
|
-0.0600
|
0.2300
|
0.2300
|
0.2400
|
-
|
-
|
Dividend per Share
|
0.1000
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
0.1250
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/02/22
|
27/04/22
|
27/07/22
|
26/10/22
|
15/02/23
|
26/04/23
|
26/07/23
|
25/10/23
|
15/02/24
|
01/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,724
|
2,702
|
2,348
|
2,374
|
2,551
|
2,468
|
2,258
|
2,069
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.429
x
|
4.045
x
|
2.479
x
|
2.713
x
|
4.868
x
|
3.881
x
|
2.919
x
|
2.502
x
|
Free Cash Flow
1 |
214
|
160
|
468
|
170
|
-77
|
156
|
266
|
307
|
ROE (net income / shareholders' equity)
|
9.22%
|
6.62%
|
15.5%
|
14.3%
|
-1.12%
|
5.63%
|
10.9%
|
10.4%
|
ROA (Net income/ Total Assets)
|
1.33%
|
1.37%
|
4.56%
|
5.06%
|
-0.39%
|
1.86%
|
3.71%
|
3.48%
|
Assets
1 |
-8,183
|
70,797
|
6,277
|
9,823
|
81,886
|
5,331
|
6,092
|
7,339
|
Book Value Per Share
2 |
5.270
|
11.80
|
13.00
|
15.30
|
12.30
|
12.60
|
13.70
|
14.50
|
Cash Flow per Share
2 |
2.950
|
2.450
|
4.690
|
3.810
|
1.180
|
2.370
|
3.260
|
2.840
|
Capex
1 |
198
|
195
|
272
|
428
|
261
|
390
|
323
|
308
|
Capex / Sales
|
7.49%
|
7.07%
|
7.61%
|
12.39%
|
9.16%
|
12.1%
|
9.37%
|
8.67%
|
Announcement Date
|
25/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
15/02/24
|
-
|
-
|
-
|
Last Close Price
19.81
USD Average target price
20.5
USD Spread / Average Target +3.48% Consensus |
1st Jan change
|
Capi.
|
---|
| +39.90% | 3.13B | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +26.97% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|